Table of contents
Expand All Topics
Metabolic dysfunction-associated steatotic liver disease
What's new
Updated 2025 ADA guidelines for the management of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes .
Guidelines
Key sources
The following summarized guidelines for the evaluation and management of metabolic dysfunction-associated steatotic liver disease are prepared by our editorial team based on guidelines from the American Association for the Study of Liver Diseases (AASLD 2025,2024,2023), the American Diabetes Association (ADA 2025), the European Association for the Study of Obesity (EASO/EASD/EASL 2024), the European Association for the Study of the ...
Show more